Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study

Background: Human immunodeficiency virus (HIV) infection is associated with an increased risk of hypercoagulability and treatment with antiretroviral agents especially protease inhibitors has also been reported to contribute to this risk. Altered fibrinolytic activity is reported as a mechanism of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Christopher, Chimeziem, Nwogoh, Benedict, Akaba, Kingsley, igwilo, Hilary, Abang, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703161/
https://www.ncbi.nlm.nih.gov/pubmed/36411985
http://dx.doi.org/10.1177/10760296221126176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703161/
https://www.ncbi.nlm.nih.gov/pubmed/36411985
http://dx.doi.org/10.1177/10760296221126176

Ejemplares similares